Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat

Seizure

Volumn 12, Issue 7, 2003, Pages 508-515

  Sechi, Gianpietro ^b   De Riu, Pierluigi ^a   Mameli, Ombretta ^c   Deiana, Giovanni A ^b   Cocco, Giovanni A ^b   Rosati, Giulio ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b Neurological Clinic   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

Author keywords

GABAA; Receptors; Status epilepticus; Thiocolchicoside

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; COLCHICINE DERIVATIVE; THIOCOLCHICOSIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ARACHNOID; BRAIN CORTEX; CLONIC SEIZURE; CONTROLLED STUDY; DRUG STRUCTURE; DURA MATER; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; MALE; MICROINJECTION; NONHUMAN; PIA MATER; PRIORITY JOURNAL; RAT; RAT STRAIN; SEIZURE; TONIC CLONIC SEIZURE;

EID: 0141717263     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(03)00053-0     Document Type: Article

References (18)

1. Janbroers, J. M. Review of the toxicology, pharmacodynamics and pharmacokinetics of thiocolchicoside, a GABA-agonist muscle relaxant with anti-inflammatory and analgesic actions. Acta Therapeutica 1987; 13: 221-227.
2. Dasheiff, R. M. and Rarirez, L. F. The effects of colchicine in mammalian brain from rodents to Rhesus monkeys. Brain Research Review 1985; 10: 47-67.
3. Wisniewski, H. and Terry, R. D. Experimental colchicine encephalopathy. Laboratory Investigation 1967; 17: 577-587.
4. Sechi, G. P., Rosati, G., Deiana, G. A. et al. Epileptogenic activity of thiocolchicoside (abstract). Epilepsia 1993; 34 (Suppl. 2): 99-100.
5. De Riu, P. L., Rosati, G., Sotgiu, S. and Sechi, G. P. Epileptic seizures after treatment with thiocolchicoside. Epilepsia 2001; 42: 1084-1086.
6. Paxinos, G. and Watson, C. The Rat Brain in Stereotaxic Coordinates, 2nd edn. San Diego, Academic Press, 1987.
7. 3H]thiocolchicoside binding sites in the rat brain and spinal cord. Neuropharmacology 2001; 40: 1044-1049.
8. 3H]strychnine binding sites in rat spinal cord and brainstem. European Journal of Pharmacology 1996; 318: 201-204.
9. 3H]thiocolchicoside binding sites in rat spinal cord and cerebral cortex. European Journal of Pharmacology 1999; 376: 149-157.
10. Matsubayashi, H., Alkondon, M., Pereira, E. F. R., Swanson, K. L. and Albuquerque, E. X. Strychnine: a potent competitive antagonist of α-Bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal neurons. Journal of Pharmacology and Experimental Therapeutics 1998; 271: 494-506.
11. Grenningloh, G. H., Rienitz, A., Schmitt, B. et al. The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors. Nature 1987; 328: 215-220.
12. Betz, H. Ligand-gated ion channels in the brain: the amino acid receptor superfamily. Neuron 1990; 5: 383-392.
13. 3H]strychnine binding sites. Brain Research Bulletin 1985; 15: 473-486.
14. Van den Pol, A. N. and Gores, T. Glycine and glycine receptor immunoreactivity in brain and spinal cord. The Journal of Neuroscience 1988; 8: 472-492.
15. Olsen, R. W. and DeLorey, T. M. GABA and glycine. In: Basic Neurochemistry: Molecular, Cellular and Medical Aspects (Eds. G. J. Siegel, B. W. Agranoff, R. W. Albers, S. K. Fisher and M. D. Uhler). Philadelphia, Lippincott-Raven, 1999: pp. 336-346.
16. Amato, G., La Grutta, V., Militello, L. and Enia, F. The function of the caudate nucleus in the control of some paroxystic activities in the neuraxis. Archives Internationales de Physiologie te de Biochimie 1969; 77: 465-484.
17. Engel, J. J. Experimental models of epilepsy: classification and relevance to human epileptic phenomena. In: Neurotransmitter in Epilepsy (Eds. G. Avanzini, J. J. Engel, R. Fariello and U. Heinemann). Amsterdam, Elsevier, 1992: pp. 9-20.
18. Löscher, W. Animal models of epilepsy and epileptic seizures. In: Antiepileptic Drugs Pharmacology and Therapeutics (Eds. M. J. Eadie and F. J. E. Vajda). Berlin, Springer, 1999: pp. 19-62.